Anabolic and cardiovascular effects of recombinant human growth hormone in surgical patients with sepsis

British Journal of Surgery

Volumn 83, Issue 2, 1996, Pages 196-202

  Koea, J B ^a   Breier, B H ^b   Douglas, R G ^a   Gluckman, P D ^b   Shaw, J H F ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; GROWTH HORMONE; HUMAN GROWTH HORMONE; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TOTAL PARENTERAL NUTRITION;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; GROWTH HORMONE; HEMODYNAMIC PROCESSES; HORMONES; HUMANS; MALE; MIDDLE AGED; PARENTERAL NUTRITION, TOTAL; PROTEINS; RECOMBINANT PROTEINS; SEPSIS; TREATMENT OUTCOME; WATER-ELECTROLYTE BALANCE;

EID: 0030050076     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830214     Document Type: Article

References (43)

1. Cerra FB. Hypermetabolism, organ failure, and metabolic support. Surgery 1987; 101: 1-14.
2. Streat SJ, Hill GL. Nutritional support in the management of critically ill patients in surgical intensive care. World J Surg 1987; 11: 194-201.
3. Windsor JA, Hill GL. Weight loss with physiologic impairment. A basic indicator of surgical risk. Ann Surg 1988; 207: 290-6.
4. Shaw JHF, Wildbore M, Wolfe RR. Whole body protein kinetics in severely septic patients. The response to glucose infusion and total parenteral nutrition. Ann Surg 1986; 205: 288-94.
5. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. New Engl J Med 1991; 325: 525-32.
6. Jiang Z-M, He G-Z, Zhang S-Y et al. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg; 1989; 210: 513-24.
7. Vara-Thorbeck R, Guerrero JA, Ruiz-Requena ME et al. Effects of growth hormone in patients receiving total parenteral nutrition following major gastrointestinal surgery, Hepatogastroenterology 1992; 39: 270-2.
8. Dunn DL. Gram-negative bacterial sepsis and sepsis syndrome. Surg Clin North Am 1994; 74: 621-35.
9. 15N-urea. Am J Physiol 1981: 240: E428-34.
10. Douglas RG, Gluckman PD, Ball K, Breier B, Shaw JHF. The effects of infusion of insulin-like growth factor. (IGF). I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs. J Clin Invest 1991; 88: 614-22.
11. Elebute EA, Stoner HB. The grading of sepsis. Br J Surg 1983; 70: 29-31.
12. Christensen T, Bendix T, Kehlet H, Fatigue and cardiorespiratory function following abdominal surgery. Br J Surg 1982; 69: 417-19.
13. Breckenridge A. Angiotensin converting enzyme inhibitors and quality of life. Am J Hypertens 1991; 4: 79-82S.
14. Hill GL, Church J. Energy and protein requirements of general surgical patients requiring intravenous nutrition. Br J Surg 1984; 71: 1-9.
15. Breier BH, Milsom S, Blum WF, Schwanch J, Gallaher BW, Gluckman PD. Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women. Acta Endocrinol (Copenh) 1993; 129: 427-35.
16. Breier BH, Gallaher BW, Gluckman PD. Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J Endocrinol 1991; 128: 347-57.
17. Wilmore DW, Moylan JA Jr, Bristow BF, Mason AD Jr, Pruitt BA Jr. Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 1974; 138: 875-84.
18. Douglas RG, Humberstone DA, Haystead A, Shaw JHF, Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition. Br J Surg 1990; 77: 785-90.
19. Ponting GA, Halliday D, Teale JD, Sim AJW. Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1988; i: 438-9.
20. Ziegler TR, Young LS, Manson JMcK, Wilmore DW. Metabolic effects of recombinant human growth hormone in patients receiving total parenteral nutrition. Ann Surg 1988; 208: 6-16.
21. Mjaaland M, Unneberg K, Larsson J, Nilsson L, Revhaug A. Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition. Ann Surg 1993; 217: 413-22.
22. Soroff HS, Rozen RR, Mooty J et al. Role of human growth hormone in the response to trauma: I. Metabolic effects following burns. Ann Surg 1967; 166: 739-52.
23. Wolf RF, Pearlstone DB, Newman F. et al. Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients. Ann Surg 1992; 216: 280-90.
24. Suchner U, Rothkopf MM, Stanislaus G, Elwyn DH, Kvetan V, Askanazi J. Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. Arch Intern Med 1990; 150: 1225-30.
25. Schulman G, Wingard RL, Hutchison RL, Laurence P, Hakim RM. The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis 1993; 21: 527-34.
26. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR, Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994; 78: 404-10.
27. Dardevet D, Sornet C, Attaix D, Baracos VE, Grizard J. Insulin-like growth factor-I and insulin resistance in skeletal muscles of adult and old rats. Endocrinology 1994; 134: 1475-84.
28. Thissen JP, Underwood LE, Maiter D, Maes M, Clemmons DR, Ketelslegers JM. Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. Endocrinology 1991; 128: 885-90.
29. Ross RJM, Miell JP, Holly JMP et al. Levels of GH binding activity, IGFBP-I, insulin, blood glucose and cortisol in intensive care patients. Clin Endocrinol (Oxf) 1991; 35: 361-7.
30. Conover CA, Powell DR. Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology 1991; 129: 710-16.
31. Fong Y, Rosenbaum M, Raman G et al. Acute effects of growth hormone on protein metabolism during intravenous refeeding. Surgical Forum 1987; 38: 54-6.
32. Dahn MS, Lange MP, Jacobs LA. Insulin-like growth factor I production is inhibited in human sepsis. Arch Surg 1988; 123: 1409-14.
33. Liledahl S-O, Gemzell C-A, Plantin L-O, Birke G. Effect of human growth hormone in patients with severe burns. Acta Chirurgica Scandinavica 1961; 122: 1-14.
34. Ziegler TR, Young LS, Ferrari-Balivieri E, Demling RH, Wilmore DW. Use of human growth hormone combined with nutritional support in a critical care unit. JPEN J Parenter Enteral Nutr 1990; 14: 574-81.
35. Souadjian JV, Schirger A. Hypertension in acromegaly. Am J Med Sci 1967; 254: 629-35.
36. Cittadini A, Cuocolo A. Merola B et al. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol 1994; 267: E219-25.
37. Cunco RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol 1991; 70: 695-700.
38. Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R, Johnston DG. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. European Journal of Endocrinology 1994; 130: 451-8.
39. Frelin C. The regulation of protein turnover in newborn rat heart cell cultures. J Biol Chem 1980; 225: 11149-55.
40. Lie JT. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980; 100: 41-52.
41. Koea JB, Douglas RG, Breier BH, Shaw JHF, Gluckman PD. Synergistic effect of insulin-like growth factor-I administration on the protein-sparing effects of total parenteral nutrition in fasted lambs. Endocrinology 1992; 131: 643-8.
42. Florini JR, Ewton DZ. Induction of gene expression in muscle by the IGFs. Growth Regul 1992; 2: 23-9.
43. Magri KA, Ewton DZ, Florini JR. The role of the IGFs in myogenic differentiation. Adv Exp Med Biol 1991; 293: 57-76.